Zeo ScientifiX, Inc.
ZEOX · OTCMCIK 1557376fmd_0GADXSAG2SWF2V9G702HBCWZ0WManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Nov 01, 2010 to Jun 30, 2026, 60 periods
| Line item | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | 0 | 1 | 1 | 2 | 3 | 6 | 6 | 5 | 5 | 5 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 |
| Net interest income | – | – | – | – | (0) | (0) | – | – | – | – |
| Gross profit | 0 | 0 | 1 | 1 | 3 | 5 | 6 | 4 | 4 | 4 |
| Research and development | – | – | – | 0 | 0 | 1 | 1 | 1 | 0 | 0 |
| Total operating expenses | 1 | 9 | – | – | – | – | – | – | – | – |
| Compensation and benefits | – | – | – | – | – | – | – | – | 0 | 0 |
| Operating income | (1) | (9) | (3) | (2) | (12) | (13) | (9) | (7) | (5) | (5) |
| Interest expense | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (0) | 1 | (0) |
| Income before taxes | – | (9) | (3) | (2) | (13) | (13) | (9) | – | – | – |
| Income tax expense | 0 | 0 | 0 | 0 | 0 | 0 | – | – | – | – |
| Net income from continuing operations | (1) | (9) | (3) | (2) | (13) | (13) | – | – | – | – |
| Net income | (1) | (9) | (3) | (2) | (13) | (13) | (9) | (7) | (5) | (6) |